M1-Type Macrophages Secrete TNF-α to Stimulate Vascular Calcification by Upregulating CA1 and CA2 Expression in VSMCs

References

• Gamble W. Atherosclerosis: the carbonic anhydrase, carbon dioxide, calcium concerted theory. J Theor Biol. 2006;239(1):16–21. doi:10.1016/j.jtbi.2005.07.008
   PubMed Web of Science ®Google Scholar
• Chinetti-Gbaguidi G, Daoudi M, Rosa M, et al. Human alternative macrophages populate calcified areas of atherosclerotic lesions and display impaired RANKL-induced osteoclastic bone resorption activity. Circ Res. 2017;121(1):19–30. doi:10.1161/CIRCRESAHA.116.310262
   PubMed Web of Science ®Google Scholar
• Allison MA, Criqui MH, Wright CM. Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(2):331–336. doi:10.1161/01.ATV.0000110786.02097.0c
   PubMed Web of Science ®Google Scholar
• Villa-Bellosta R. New insights into endogenous mechanisms of protection against arterial calcification. Atherosclerosis. 2020;306:68–74. doi:10.1016/j.atherosclerosis.2020.03.007
   PubMed Web of Science ®Google Scholar
• Waring OJ, Skenteris NT, Biessen EAL, Donners M. Two-faced Janus: the dual role of macrophages in atherosclerotic calcification. Cardiovasc Res. 2022;118(13):2768–2777. doi:10.1093/cvr/cvab301
   PubMed Web of Science ®Google Scholar
• Adeva-Andany MM, Fernández-Fernández C, Sánchez-Bello R, Donapetry-García C, Martínez-Rodríguez J. The role of carbonic anhydrase in the pathogenesis of vascular calcification in humans. Atherosclerosis. 2015;241(1):183–191. doi:10.1016/j.atherosclerosis.2015.05.012
   PubMed Web of Science ®Google Scholar
• Zamanova S, Shabana AM, Mondal UK, Ilies MA. Carbonic anhydrases as disease markers. Expert Opin Ther Pat. 2019;29(7):509–533. doi:10.1080/13543776.2019.1629419
   PubMed Web of Science ®Google Scholar
• Rahman S, Bibi S, Javed T, et al. Review: therapeutic potential of carbonic anhydrase inhibitors. Pak J Pharm Sci. 2019;32(2):709–720.
   PubMed Web of Science ®Google Scholar
• Yuan L, Wang M, Liu T, et al. Carbonic anhydrase 1-mediated calcification is associated with atherosclerosis, and methazolamide alleviates its pathogenesis. Front Pharmacol. 2019;10:766. doi:10.3389/fphar.2019.00766
   PubMed Web of Science ®Google Scholar
• Song X, Li P, Li Y, et al. Strong association of glaucoma with atherosclerosis. Sci Rep. 2021;11(1):8792. doi:10.1038/s41598-021-88322-4
   PubMed Web of Science ®Google Scholar
• Ando T, Iizuka N, Sato T, et al. Autoantigenicity of carbonic anhydrase 1 in patients with abdominal aortic aneurysm, revealed by proteomic surveillance. Hum Immunol. 2013;74(7):852–857. doi:10.1016/j.humimm.2013.02.009
   PubMed Web of Science ®Google Scholar
• Oksala N, Levula M, Pelto-Huikko M, et al. Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques-Tampere Vascular Study. Ann Med. 2010;42(5):360–370. doi:10.3109/07853890.2010.486408
   PubMed Web of Science ®Google Scholar
• Argan O, Çıkrıkçı K, Baltacı A, Gencer N. The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes. J Enzyme Inhib Med Chem. 2020;35(1):1359–1362. doi:10.1080/14756366.2020.1781844
   PubMed Web of Science ®Google Scholar
• Li Y, Sun Z, Zhang L, et al. Role of macrophages in the progression and regression of vascular calcification. Front Pharmacol. 2020;11:661. doi:10.3389/fphar.2020.00661
   PubMed Web of Science ®Google Scholar
• de Gaetano M, Crean D, Barry M, Belton O. M1- and M2-type macrophage responses are predictive of adverse outcomes in human atherosclerosis. Front Immunol. 2016;7:275. doi:10.3389/fimmu.2016.00275
   PubMed Web of Science ®Google Scholar
• Farias-Itao DS, Pasqualucci CA, de Andrade RA, et al. Macrophage polarization in the perivascular fat was associated with coronary atherosclerosis. J Am Heart Assoc. 2022;11(6):e023274. doi:10.1161/JAHA.121.023274
   PubMed Web of Science ®Google Scholar
• Rahal OM, Wolfe AR, Mandal PK, et al. Blocking Interleukin (IL)4- and IL13-mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects against macrophage-mediated radioresistance of inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2018;100(4):1034–1043. doi:10.1016/j.ijrobp.2017.11.043
   PubMed Web of Science ®Google Scholar
• Tian BY, Yao L, Sheng ZT, et al. Specific knockdown of WNT8b expression protects against phosphate-induced calcification in vascular smooth muscle cells by inhibiting the Wnt-β-catenin signaling pathway. J Cell Physiol. 2019;234(4):3469–3477. doi:10.1002/jcp.26827
   PubMed Web of Science ®Google Scholar
• Eshghjoo S, Kim DM, Jayaraman A, Sun Y, Alaniz RC. Macrophage Polarization in Atherosclerosis. Genes. 2022;13(5):756. doi:10.3390/genes13050756
   PubMed Web of Science ®Google Scholar
• Momtazi-Borojeni AA, Abdollahi E, Nikfar B, Chaichian S, Ekhlasi-Hundrieser M. Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy. Heart Fail Rev. 2019;24(3):399–409. doi:10.1007/s10741-018-09764-z
   PubMed Web of Science ®Google Scholar
• Nikiforov NG, Elizova NV, Bukrinsky M, et al. Use of primary macrophages for searching novel immunocorrectors. Curr Pharm Des. 2017;23(6):915–920. doi:10.2174/1381612823666170125110128
   PubMed Web of Science ®Google Scholar
• DePalma RG, Hayes VW, Cafferata HT, et al. Cytokine signatures in atherosclerotic claudicants. J Surg Res. 2003;111(2):215–221. doi:10.1016/S0022-4804(03)00075-1
   PubMed Web of Science ®Google Scholar
• Cao H, Jia Q, Shen D, et al. Bushen Jiangzhi formula reduces atherosclerosis in apoE-/- mice through autophagy. J Tradit Chin Med. 2020;40(4):593–601. doi:10.19852/j.cnki.jtcm.2020.04.008
   PubMed Web of Science ®Google Scholar
• Gonzalez Rodriguez A, Schroeder ME, Grim JC, et al. Tumor necrosis factor-α promotes and exacerbates calcification in heart valve myofibroblast populations. FASEB J. 2021;35(3):e21382. doi:10.1096/fj.202002013RR
   PubMed Web of Science ®Google Scholar
• Králová A, Králová Lesná I, Poledne R. Immunological aspects of atherosclerosis. Physiol Res. 2014;63(Suppl 3):S335–S342. doi:10.33549/physiolres.932858
   PubMedGoogle Scholar
• Tam LS, Kitas GD, González-Gay MA. Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology. 2014;53(6):1108–1119. doi:10.1093/rheumatology/ket454
   PubMed Web of Science ®Google Scholar
• Bennet AM, van Maarle MC, Hallqvist J, et al. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis. 2006;187(2):408–414. doi:10.1016/j.atherosclerosis.2005.09.022
   PubMed Web of Science ®Google Scholar